Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK- Positive Non-Small Cell Lung Cancer
Cancer Communications · 01.01.2026 · 46
DOI: 10.34133/cancomm.0031 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cancer Communications, online erschienen am 21.05.2026. Verfasst von Daan A C Lanser und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Zuid-Holland, the Netherlands. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Zuid-Holland, the Netherlands.
- Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Zuid-Holland, the Netherlands.
- Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, Zuid-Holland, the Netherlands.
- Department of Pulmonary Medicine, University of Groningen, University Medical Center Groningen, Groningen, Groningen, the Netherlands.
- Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, Noord-Holland, the Netherlands.
- Department of Pulmonary Medicine, Amsterdam University Medical Center, Amsterdam, Noord-Holland, the Netherlands.
ORCID-Profile: Daan A C Lanser, Niels Heersche, M Benthe Muntinghe-Wagenaar, Ma Ida Mohmaed Ali, Ezgi B Ulas, Evert de Jonge, Esther Oomen-de Hoop, Marthe S Paats, Idris Bahce, Sander Croes, Adrianus J Langen, Lizza E L Hendriks, Anthonie J Wekken, Alwin D R Huitema, Ron H N Schaik, Anne-Marie C Dingemans, G D Marijn Veerman, Ron H J Mathijssen
Zitieren
APA
Lanser, D. A. C., Heersche, N., Muntinghe-Wagenaar, M. B., Ali, M. I. M., Ulas, E. B., de Jonge, E., Hoop, E. O., Paats, M. S., Bahce, I., Croes, S., Langen, A. J., Hendriks, L. E. L., Wekken, A. J., Huitema, A. D. R., Schaik, R. H. N., Dingemans, A. C., Veerman, G. D. M., & Mathijssen, R. H. J. (2026). Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK- Positive Non-Small Cell Lung Cancer. Cancer Communications, 46. https://doi.org/10.34133/cancomm.0031
Vancouver
Lanser DAC, Heersche N, Muntinghe-Wagenaar MB, Ali MIM, Ulas EB, de Jonge E, et al. Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK- Positive Non-Small Cell Lung Cancer. Cancer Communications. 2026;46. doi:10.34133/cancomm.0031
BibTeX
@article{Lanser2026,
author = {Lanser, Daan A C and Heersche, Niels and Muntinghe-Wagenaar, M Benthe and Ali, Ma Ida Mohmaed and Ulas, Ezgi B and de Jonge, Evert and Hoop, Esther Oomen-de and Paats, Marthe S and Bahce, Idris and Croes, Sander and Langen, Adrianus J and Hendriks, Lizza E L and Wekken, Anthonie J and Huitema, Alwin D R and Schaik, Ron H N and Dingemans, Anne-Marie C and Veerman, G D Marijn and Mathijssen, Ron H J},
title = {Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK- Positive Non-Small Cell Lung Cancer},
journal = {Cancer Communications},
year = {2026},
volume = {46},
doi = {10.34133/cancomm.0031}
}
EUVIMED